Publikationen von U. Reichl

Genzel, Y.; König, S.; Reichl, U.: Amino acid analysis in mammalian cell culture based virus vaccine production processes. IICS : 17th annual International Ion Chromatography Symposium, Trier, Germany (2004)

Rapp, E.; Lubda, D.; Seidel-Morgenstern, A.; Reichl, U.; Tallarek, U.: Sheathless ESI-Interface for Coupling Capillary Separation Techniques to Mass Spectromety. 37. Diskussionstagung der Deutschen Gesellschaft für Massenspektrometrie, Leipzig, Germany (2004)

Daumal, C.; Jacobtorweihe, L.; Behrendt, I.; Ermert, D.; Semmrich, M.; Genzel, Y.; Reichl, U.: Optimizing the Production of Oncolytic Herpes Simplex-1 Virus in Suspension HEK293 Cells. 5^th ESACT Frontiers Retreat, Ljubljana (Slovenia) (2025)

Dogra, T.; Pelz, L.; Rüdiger, D.; Hein, M.; Baelkner, M.; Boehme, J.D.; Marichal-Gallardo, P.; Genzel, Y.; Bruder, D.; Kupke, S. Y. et al.; Reichl, U.: Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 9^th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)

Jacobtorweihe, L.; Braatz, F.; Brice, M.; Léon, A.; Genzel, Y.; Reichl, U.: Intensification of oncolytic Newcastle disease virus production using EB66 duck cells in perfusion mode. 5^th ESACT Frontiers Retreat, Ljubljana (Slovenia) (2025)

Jacobtorweihe, L.; Braatz, F.; Madeline, B.; Léon, A.; Genzel, Y.; Reichl, U.: Production of Oncolytic Newcastle Disease Virus in EB66 cells: Characterization of Parameters for Process Intensification. Cell Culture Engineering (CCE) XIX, Tucson Arizona (USA) (2025)

Küchler, J.; Opitz, P.; Jordan, I.; Genzel, Y.; Benndorf, D.; Reichl, U.: Quantification of intracellular influenza A virus proteins shows changes in dynamics related to host cell line and virus seed. 9^th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)

Pelz, L.; Dogra, T.; Rüdiger, D.; Boehme, J.; Kershaw, O.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Influenza A Defective Interfering Particles as Broad-Spectrum Antivirals. Cell Culture Engineering (CCE) XIX, Tucson Arizona (USA) (2025)

Piasecka, J.; Kupke, S. Y.; Reichl, U.: Genetically engineered influenza defective interfering particles with enhanced immune activation potential and antiviral efficacy in vitro. 9^th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)

Piasecka, J.; Rüdiger, D.; Küchler, J.; Kupke, S. Y.; Reichl, U.: Molecular basis for the antiviral activity of the influenza defective interfering particle “OP7”. 34^th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)

Rüdiger, D.; Piasecka, J.; Küchler, J.; Kupke, S. Y.; Reichl, U.: The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanisms. 34^th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)

Rüdiger, D.; Piasecka, J.; Küchler, J.; Kupke, S. Y.; Reichl, U.: The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanisms. 9^th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)

Dogra, T.; Pelz, L.; Rüdiger, D.; Hein, M. D.; Böhme, J.; Bälkner, M.; Kershaw, O.; Marichal-Gallardo, P.; Gruber, A.; Genzel, Y. et al.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Genetically engineered defective interfering particles for antiviral treatment and vaccination. 28th ESACT Meeting, Edingburgh (Scotland) (2024)

Göbel, S.; Pelz, L.; Silva, C.; Brühlmann, B.; Hill, C.; Altomonte, J.; Kamen, A.; Reichl, U.; Genzel, Y.: Intensified production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration. 28th ESACT Meeting, Edingburgh (Scotland) (2024)

Jacobtorweihe, L.; Göbel, S.; Wolschek, M.; Altomonte, J.; Reichl, U.; Genzel, Y.: HCD Perfusion of CCX.E10 Quail Cells for Production of Vesicular Stomatitis Virus based oncolytic Vaccine. Vaccine Technology IX, Los Cabos (Mexico) (2024)

Jacobtorweihe, L.; Göbel, S.; Wolschek, M.; Altomonte, J.; Reichl, U.; Genzel, Y.: Production of Oncolytic rVSV-NDV in CCX.E10 Quail Cells by HCD Perfusion Culture. Himmelfahrtstagung on Bioprocess Engineering 2024, Regensburg (Germany) (2024)

Jacobtorweihe, L.; Madeline, B.; Léon, A.; Genzel, Y.; Reichl, U.: Production of Oncolytic Newcastle Disease Virus in EB66 cells. 28th ESACT Meeting, Edingburgh (Scotland) (2024)

Küchler, J.; Opitz, P.; Jordan, I.; Genzel, Y.; Benndorf, D.; Reichl, U.: Quantification of intracellular influenza A virus proteins shows changes in dynamics related to host cell line and virus seed. 28th ESACT Meeting , Edingburgh (Scotland) (2024)

Küchler, J.; Opitz, P.; Jordan, I.; Genzel, Y.; Benndorf, D.; Reichl, U.: Quantification of intracellular influenza A virus proteins shows changes in dynamics related to host cell line and virus seed. Himmelfahrtstagung on Bioprocess Engineering 2024, Regensburg (Germany) (2024)

Pelz, L.; Dogra, T.; Rüdiger, D.; Boehme, J.; Kershaw, O.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Defective Interfering Particles of Influenza A Virus As Broad-Spectrum Antivirals. 33^rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)